{"entity":{"id":"stonewise","kind":"company","name":"StoneWise","aka":["Beijing StoneWise Technology Co., Ltd.","望石智慧"],"tldr":"StoneWise builds AI software that designs new drug molecules, sells it to drug companies, and has started testing its own first cancer drug in people.","summary":"Beijing StoneWise Technology Co., Ltd. (望石智慧), headquartered in Haidian, Beijing with a Shanghai office, develops MolVado, a multimodal AI model that generates 3D small molecules, together with computational chemistry tools, and offers them to drug developers; it also develops its own oral small-molecule candidates. Its company page states it has completed several financing rounds totalling more than USD 100 million. SWA1211 tablets are in a first-in-human phase 1 study in advanced solid tumours (NCT07363967). Its first registered cancer trial, NCT07363967, was posted on ClinicalTrials.gov in January 2026.","asOf":"2026-10-29","links":[{"label":"Official website","url":"https://www.stonewise.cn/"},{"label":"About us","url":"https://www.stonewise.cn/about-us"},{"label":"ClinicalTrials.gov: phase 1 trial of SWA1211 (NCT07363967)","url":"https://clinicaltrials.gov/study/NCT07363967"}],"tags":[],"related":[],"cancers":[],"sections":["ai-computation","drug-discovery"],"technologies":["ai-drug-design"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Company website (Chinese) read on 29 October 2026. Founding year not stated on the pages read. The target of SWA1211 is not disclosed on the website or in the registry record. Cumulative financing of more than USD 100 million is the company's own statement; individual rounds were not read, so no funding rows are recorded."],"hq":"Beijing","country":"CN","companyType":"ai-software","website":"https://www.stonewise.cn/","stage":"growth","investors":[],"funding":[]},"route":"/companies/stonewise/","neighbours":{"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"technology":[{"id":"ai-drug-design","kind":"technology","name":"AI-driven drug & target discovery","route":"/technologies/ai-drug-design/"}]}}